Largest Global Study Validates TruScreen as Superior Cervical Cancer Screening Tool

• Largest international opto-electronic cervical screening study with nearly 15,000 women
• TruScreen shows higher sensitivity and negative predictive value than Liquid Based Cytology
• Performance comparable to high-risk HPV DNA testing for detecting severe precancerous lesions
• Study published in respected BMC Cancer journal and endorsed by Chinese medical associations